Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

High CHD risk in diabetic women confirmed

A meta-analysis confirms that the excess risk for coronary heart disease in patients with diabetes is greater in women than men.

5 Jun 2014

Navigated brain stimulation system may help improve motor function for people recovering from stroke

Researchers at Shepherd Center are studying whether stimulating the brain before rehabilitation could yield greater gains in motor function for people recovering from stroke.

5 Jun 2014

Study reveals molecular mechanism of cell death

Researchers at VIB and Ghent University have unraveled the mechanism of necroptosis. This is a type of cell death that plays a crucial role in numerous diseases, from viral infections and loss of auditory nerve cells to multiple sclerosis, acute heart failure and organ transplantation.

5 Jun 2014

Researchers examine how high blood pressure in middle age affects memory and thinking in old age

New research suggests that high blood pressure in middle age plays a critical role in whether blood pressure in old age may affect memory and thinking.

5 Jun 2014

New gene involved in Parkinson's disease, find researchers

A team of UCLA researchers has identified a new gene involved in Parkinson's disease, a finding that may one day provide a target for a new drug to prevent and potentially even cure the debilitating neurological disorder.

5 Jun 2014

Scientist unlocks potential of stem cells for repairing neural damage to brain

A QUT scientist is hoping to unlock the potential of stem cells as a way of repairing neural damage to the brain.

5 Jun 2014

PointRight releases PointRight Pro 30 to track and reduce rehospitalization rates

PointRight Inc., providing industry-standard analytics for healthcare providers and payers, announces the release of PointRight® Pro 30™, an upgraded version of its popular tools leveraging big data to track and reduce rehospitalization rates in long-term care (LTC) facilities.

5 Jun 2014

Researchers emphasize critical need to utilize multi-pronged approach to treat diabetes mellitus

Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University; Marc A. Pfeffer, M.D., Dzau professor of medicine at Harvard Medical School; John W. Newcomer, M.D., executive vice dean of FAU's College of Medicine and interim vice president for research at FAU; Paul S. Jellinger, M.D., affiliate professor at the University of Miami Miller School of Medicine; and Alan Garber, M.D., Ph.D., professor of medicine at Baylor, have published a commentary in the American Journal of Managed Care titled "Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial Interventions."

4 Jun 2014

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte Corporation (Nasdaq: INCY) today announced results from the RESPONSE trial, the first pivotal Phase III study evaluating a JAK1/JAK2 inhibitor for the treatment of polycythemia vera (PV).

4 Jun 2014

NeuroVive extends collaboration with Hospices Civils de Lyon

NeuroVive is extending its collaboration with Hospices Civils de Lyon (HCL) and Professor Ovize, which broadens the scope of NeuroVive's cardiovascular business area and creates the right conditions for the company to retain its leading position in mitochondrial medicine.

4 Jun 2014

Unsterile living conditions, untrained caregivers contribute to infections in home health settings

Millions of Americans depend on home health care services to recover from surgeries and hospital stays, as well as to manage daily life with chronic conditions.

4 Jun 2014

Penn and Mayo Clinic researchers launch Seizure Detection Challenge

Researchers from Mayo Clinic and the University of Pennsylvania announce the launch of the Seizure Detection Challenge, an international competition inviting the best minds in "machine learning" to improve devices to track and treat epilepsy.

3 Jun 2014

Duke researchers identify first piece of new brain-repair circuit

Duke researchers have found a new type of neuron in the adult brain that is capable of telling stem cells to make more new neurons. Though the experiments are in their early stages, the finding opens the tantalizing possibility that the brain may be able to repair itself from within.

3 Jun 2014

Sound Physicians agrees to employ, manage hospitalist physicians at Mercy Hospital & Medical Center

Sound Physicians, a leading hospitalist organization focused on driving improvements in the quality, satisfaction and financial performance of inpatient healthcare delivery, announced today an agreement to employ and manage a team of hospitalist physicians at Mercy Hospital & Medical Center in Chicago, Ill.

3 Jun 2014

Study warns against use of resveratrol supplements by pregnant women

A widely available dietary supplement that had been considered safe - and that some claim provides anti-aging and other health benefits - caused significant developmental abnormalities in the pancreas of offspring of pregnant monkeys who were given the supplement, according to a study published today in the FASEB Journal, from the Federation of American Societies of Experimental Biology.

3 Jun 2014

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals plc today presented data from the Phase 2b study evaluating JZP-110 (formerly known as ADX-N05) as a potential new treatment for the symptoms of excessive daytime sleepiness (EDS) in adults with narcolepsy.

3 Jun 2014

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

We already understand the many steps involved in blood clotting in great mechanistic detail. The process of blood vessels closing off in response to injury is necessary for preserving life, but blood platelets that are over-active, or activated inappropriately because of unstable plaque, can lead to heart attacks and strokes.

3 Jun 2014

Cerenis’ SAMBA and MODE Phase II Studies Meet Primary Endpoints for Treatment of FPHA, HoFH

Cerenis Therapeutics, the biopharmaceutical company, today announced that two of its Phase II studies, SAMBA and MODE (Modifying Orphan Disease Evaluation), with CER-001, an engineered human apoA-I-containing pre-β HDL mimetic, met their primary clinical endpoints in patients with Familial Primary Hypoalphalipoproteinemia (FPHA) and Homozygous Familial Hypercholesterolemia (HoFH), respectively.

2 Jun 2014

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

ARIAD Pharmaceuticals, Inc. today announced, for the first time, data from its Phase 2 trial of Iclusig (ponatinib) in adult patients with refractory metastatic and/or unresectable gastrointestinal stromal tumors (GIST).

2 Jun 2014

Scientists use a flash of light to erase and restore memory

Using a flash of light, scientists have inactivated and then reactivated a memory in genetically engineered rats. The study, supported by the National Institutes of Health, is the first cause-and-effect evidence that strengthened connections between neurons are the stuff of memory.

2 Jun 2014

Stroke News and Research

Further Reading

High CHD risk in diabetic women confirmed

Navigated brain stimulation system may help improve motor function for people recovering from stroke

Study reveals molecular mechanism of cell death

Researchers examine how high blood pressure in middle age affects memory and thinking in old age

New gene involved in Parkinson's disease, find researchers

Scientist unlocks potential of stem cells for repairing neural damage to brain

PointRight releases PointRight Pro 30 to track and reduce rehospitalization rates

Researchers emphasize critical need to utilize multi-pronged approach to treat diabetes mellitus

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

NeuroVive extends collaboration with Hospices Civils de Lyon

Unsterile living conditions, untrained caregivers contribute to infections in home health settings

Penn and Mayo Clinic researchers launch Seizure Detection Challenge

Duke researchers identify first piece of new brain-repair circuit

Sound Physicians agrees to employ, manage hospitalist physicians at Mercy Hospital & Medical Center

Study warns against use of resveratrol supplements by pregnant women

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

Cerenis’ SAMBA and MODE Phase II Studies Meet Primary Endpoints for Treatment of FPHA, HoFH

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

Scientists use a flash of light to erase and restore memory

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News